John Kozarich

John W.
Kozarich is currently Chief Executive Officer & Director at Nucorion Pharmaceuticals, Inc., Chairman at Ligand Pharmaceuticals, Inc., Adjunct Professor at The Scripps Research Institute, Trustee at Gordon Research Conferences, and Adjunct Professor at The University of Texas at Austin.
Former positions include Chief Executive Officer & Director at QLT, Inc., Chief Executive Officer & Director at Curza Global LLC, Chairman, President & Chief Science Officer at ActivX Biosciences, Inc., Chairman at Intec Pharma Ltd., Director at Poxel SA, Director at Adaptive Therapeutics, Inc., Independent Non-Executive Director at Corium LLC (Massachusetts), Independent Director at Travere Therapeutics, Inc., Director at Novelion Therapeutics, Inc., Vice President-Research & Development at Alkermes, Inc., Professor at the University of Maryland, Professor at Yale School of Medicine, and Vice President at Merck Research Laboratories Massachusetts LLC.
Education includes a doctorate from Massachusetts Institute of Technology and an undergraduate degree from Boston College.